WASHINGTON — The pharmaceutical industry is not lobbying senators to stop the confirmation of long-time critic Robert F. Kennedy Jr. to the top health care role in the Trump administration.
RFK Jr., President-elect Trump’s pick to run the Department of Health and Human Services, has lambasted the pharmaceutical industry and spread discredited ideas about vaccines.
He’s accused drugmakers of masterminding “mass poisoning” of Americans to make them sicker for profit, of spending vast sums of money to control regulatory agencies and media organizations, and of conspiring with federal agencies to undermine alternative treatments for Covid-19. He threatened to “prosecute and jail the perpetrators” of “pharma corruption,” specifically pointing to Pfizer. He claimed President Trump engaged in “legalized bribery” tied to the pharma industry during his first presidency and appointed “pharma shills high in his administration.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in